Literature DB >> 30949405

Irradiation-induced dynamic changes of gene signatures reveal gain of metastatic ability in nasopharyngeal carcinoma.

Donghui Wang1,2, Haidan Luo1,2, Zijun Huo2, Meikuang Chen3,4, Zhenbo Han4, Mienchie Hung4,5, Bojin Su1, Yong Li6, Xin Wang7, Xiang Guo8, Haipeng Xiao9, Dungfang Lee2,3, Ruiying Zhao2, Huiling Yang1.   

Abstract

Nasopharyngeal carcinoma (NPC), arising from the nasopharynx epithelium, is prevalent among South and East Asia. The radiotherapy is the primary treatment for NPC patients. However, the acquired radioresistance dramatically diminishes the therapeutic effect of radiotherapy. Meanwhile, recurrence and metastasis always occur in line with the radioresistance, but the underlying mechanisms are still unclear. In this study, we established two radioresistant NPC cell lines, CNE1R and SUNE1R, by sequentially irradiated parental CNE1 and SUNE1 cells up to a clinical treatment dose of 72 Gy. A transcriptome profile analysis of CNE1R and CNE1 reveals that activated oncogenic pathways are highly enriched in CNE1R. As the result, CNE1R showed higher proliferation rate but lower apoptosis rate after irradiation, and enhanced metastasis ability in comparison with CNE1. Significantly, a group of metastasis associated genes were increased in CNE1R while the irradiation proceeded, including several matrix metallopeptidase (MMP) members, especially MMP10 and MMP13. With further analysis, we found both MMP10 and MMP13 are highly upregulated in metastatic head and neck cancer specimens compared to non-metastatic ones. More importantly, patients with lower expression of both MMP10 and MMP13 showed a better five-year survival than the double high group. Our findings unveiled the potential mechanisms of radioresistance related metastasis in NPC patients, and the increase of MMP10 and MMP13 may serve as high risk factors for metastasis during radiotherapy.

Entities:  

Keywords:  Nasopharyngeal carcinoma; head and neck squamous cell carcinoma; matrix metallopeptidase; metastasis; radioresistance

Year:  2019        PMID: 30949405      PMCID: PMC6448059     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  4 in total

1.  Resveratrol Suppresses Human Nasopharyngeal Carcinoma Cell Growth Via Inhibiting Differentiation Antagonizing Non-Protein Coding RNA (DANCR) Expression.

Authors:  Jiafeng Zhang; Xiaojie Jin; Chuan Zhou; Hui Zhao; Ping He; Yalin Hao; Qiongna Dong
Journal:  Med Sci Monit       Date:  2020-07-19

2.  Contrast-enhanced Ultrasound in evaluating of angiogenesis and tumor staging of nasopharyngeal carcinoma in nude mice.

Authors:  ShouJun Liang; Yong Gao; YaoLi Liu; ChengCheng Qiu; YanHao Chen; ShangYong Zhu
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

3.  Differential Expression and Alternative Splicing of Transcripts Associated With Cisplatin-Induced Chemoresistance in Nasopharyngeal Carcinoma.

Authors:  Jian Zhang; Huali Jiang; Tao Xie; Jieling Zheng; Yunhong Tian; Rong Li; Baiyao Wang; Jie Lin; Anan Xu; Xiaoting Huang; Yawei Yuan
Journal:  Front Genet       Date:  2020-02-25       Impact factor: 4.599

4.  Increased MCL-1 synthesis promotes irradiation-induced nasopharyngeal carcinoma radioresistance via regulation of the ROS/AKT loop.

Authors:  Ying-Ying Liang; Fei-Yu Niu; An-An Xu; Li-Li Jiang; Chun-Shan Liu; Hui-Ping Liang; Yu-Fan Huang; Xun-Fan Shao; Zhi-Wen Mo; Ya-Wei Yuan
Journal:  Cell Death Dis       Date:  2022-02-08       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.